US Broker Ratings

Veracyte, Inc. (VCYT) Stock Analysis: Exploring an 18% Potential Upside in Diagnostics

Veracyte, Inc. (VCYT), a leading player in the healthcare diagnostics and research industry, continues to capture investor attention with its innovative genomic testing solutions. Headquartered in South San Francisco, Veracyte..

Neogen Corporation (NEOG) Stock Analysis: A Potential 37% Upside in the Healthcare Diagnostics Sector

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specifically within the diagnostics and research industry, presents a unique opportunity for investors seeking exposure to the burgeoning field..

Viridian Therapeutics (VRDN) Stock Analysis: Exploring the 75% Potential Upside in Biotech

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a promising player in the biotechnology sector, has been catching the eye of investors thanks to its significant potential upside of 75.27%. Headquartered in Waltham,..

Agios Pharmaceuticals (AGIO) Stock Analysis: Exploring a Potential 18.84% Upside for Biotech Investors

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands out in the biotech industry with its pioneering work in cellular metabolism. Headquartered in Cambridge, Massachusetts, Agios is making significant strides in developing treatments..

Harmony Biosciences Holdings, Inc. (HRMY) Stock Analysis: A 61% Upside Potential Beckons Investors

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector with its innovative approach to treating rare neurological diseases. With a market capitalization of $1.59 billion, Harmony..

ICU Medical, Inc. (ICUI) Stock Analysis: Potential 51.94% Upside Beckons Investors

Investors searching for compelling opportunities in the healthcare sector might do well to consider ICU Medical, Inc. (NASDAQ: ICUI), a notable player in the medical instruments and supplies industry. With..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Navigating a 5.92% Potential Upside Amidst Biotech Growth

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Canadian biopharmaceutical company, has been attracting attention with its promising growth trajectory in the biotechnology sector. With a market capitalization of $1.73 billion, Aurinia..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 65.25% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a prominent player in the healthcare sector, has been making waves in the medical devices industry with its innovative solutions. Headquartered in Newburyport, Massachusetts, the..

Amedisys Inc (AMED) Stock Analysis: Evaluating Growth Potential in the Healthcare Sector

Amedisys Inc (AMED), a prominent player within the healthcare sector, operates as a key provider of home health, hospice, and high acuity care services across the United States. With a..

Indivior PLC (INDV) Investor Outlook: Analyzing a 21% Upside in the Healthcare Sector

Indivior PLC (INDV), a prominent name in the healthcare sector, is gaining traction among investors seeking exposure to the drug manufacturing industry, specifically in the specialty and generic markets. Headquartered..

Vericel Corporation (VCEL): Investor Outlook on a Biotech Stock with 73% Potential Upside

Investors with a keen interest in the biotechnology sector may find Vericel Corporation (NASDAQ: VCEL) an intriguing prospect, considering its significant growth potential and market positioning. With a market capitalization..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating Growth with a 16.8% Revenue Surge and Strategic Home Care Services

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), with its current market cap standing at $1.85 billion, is carving a niche in the healthcare sector by focusing on home care services. Headquartered..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Insights into Its 2.24% Upside Potential

Pediatrix Medical Group, Inc. (NYSE: MD) stands as a significant player in the Healthcare sector, specifically within the Medical Care Facilities industry. With a market capitalization of $1.42 billion, this..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 24% Potential Upside in the Medical Devices Arena

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, has captured the attention of investors with its innovative contributions to the medical devices industry. Headquartered in London, the..

PACS Group, Inc. (PACS) Stock Analysis: A 150% Upside Potential in the Healthcare Sector

PACS Group, Inc. (PACS), a significant player in the healthcare sector, is capturing investor attention with its remarkable potential for growth. As a medical care facilities company operating primarily in..

Omnicell, Inc. (OMCL) Stock Analysis: Potential Upside of 45% Captures Investor Attention

Omnicell, Inc. (NASDAQ: OMCL), a key player in the healthcare sector, is making waves with a promising potential upside of 45.02%, according to recent analyst ratings. This healthcare information services..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Eyeing a 41.66% Potential Upside with Promising Pipeline

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a U.S.-based biopharmaceutical company, is at the forefront of developing innovative therapies for retinal diseases and other ocular conditions. With a market capitalization of $2.18..

Sotera Health Company (SHC) Stock Analysis: Understanding Its Modest 1.59% Potential Upside

Sotera Health Company (NASDAQ: SHC) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $4.49 billion, Sotera Health..

Dynavax Technologies (DVAX) Stock Analysis: Unveiling a Potential 136% Upside for Investors

As the global healthcare sector continues to expand, Dynavax Technologies Corporation (NASDAQ: DVAX) emerges as a noteworthy player in the biopharmaceutical landscape. With a current market capitalization of $1.15 billion,..

Bausch Health Companies Inc. (BHC) Investor Outlook: Exploring a 9.48% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC) has emerged as a compelling consideration for investors eyeing the healthcare sector, particularly within the specialty and generic drug manufacturing niche. With its operations..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds